Abingworth (company)

Abingworth is a life-science investment firm that has been investing in biotech and biopharma companies since making its first investment in 1987. Based in London, New York and San Francisco, the firm says it has invested in more than a hundred young companies over the decades, helping entrepreneurs turn scientific discoveries into new treatments for patients. Abingworth describes its approach as providing time, patience, capital and experience to its portfolio companies as they progress through early-stage development. The firm has also developed its own investment structures, including what it calls Venture Investments in Public Equities and a Clinical Co-Development model, alongside its core early-stage investing strategy. Its presence on both sides of the Atlantic is intended to keep the firm connected to developments in the main biotech hubs in the UK and US.